Science will prevail.

IMO it's going to be huge, OS benefit and long tail on the radar! Stay tuned!

Next week is going to be huge!

Did you see it, too?

Times fly! lol!

I am not going to explain it to you.

Shhhhhhhhh, volume drying up, watch it...

Watch out today's close!

The big miss?

Could someone tell me when the interim blinded data of the Sep 17's 8k will come out?

Quite easy to guess how much 250m shares used to raise money would last at these prices. So why it's easy to have a simple guess, it's out of reach how could someone guess it could take two years.

So will you vote yes or no?

Finally!

The part about imaging, in my opinion, seems to confirm the recent guess some smart ppl in this message board had on pfs' possible outcome.

You mean that the pub won't have material info in your opinion?

Question: is the release of interim blinded data in the control of the co.?

You must have patience, please wait.

I already expressed my personal positive view on the pipeline. There are also other positives that I see. Personally I am only a bit concerned about the amount of debt. That's my personal view.

Well, maybe there still are other options. For instance, if they could do a debt for equity swap for as much as 6M$ that would also immediately change SE numbers. If I do remember correctly by reading the 10k, its major shareholder owns 6$ of ltd and could be perhaps interested in converting it (thus increasing total holdings to a little less than 40%). This is obviously just my personal opinion, so please check it yourself and do your own dd.

Lummy is 1.2M to my math. That milestone payment doesn't say if it was immediate or dependant on any triggering event (or at least I didn't find it in a quick look in the 10K so please check back). Add April's cash usage (800K?), so if that math is correct it could mean IMO more or less that the co. should still raise more or less 6M$.

It seems about 7.3M. Actually what I couldn't find yet in a quick look is how much cash they used in Q1, any clue?

Not royalties, milestone payment.

Gee, 25% PFS at 30 months I would be impressed, too!

Right now the most important thing is to know how they intend to reach the 2.5 SE (if they are pursuing it). I suspect they might continue to raise money through the ATM, but probably right now, if some buyers shows up, it would be better to go with the sale of preferred shares. One thing is for sure, if it wasn't for the amount of debt, I believe this market cap would be considered ridicolous for a co. with such an interesting pipeline.

From today's 10K:

"In addition, in January 2018 we entered into a stock purchase agreement with Lummy (Hong Kong), Ltd., or Lummy, under which we agreed to issue and sell to Lummy in a private financing 375,000 shares of common stock for an aggregate purchase price of $1.5 million. In March 2018, we and Lummy amended the stock purchase agreement to reduce the aggregate price for the shares to $450,000. Concurrent with such amendment, we entered into an amendment to our license agreement with Lummy pursuant to which Lummy agreed to pay us a $1.05 million milestone payment."

Add "approximately $7.3 million in net proceeds that the Company has raised from the sale of its common stock in its at-the-market facility during the first quarter of 2018" and subtract cash used in first quarter plus cash to be used in April till almost the end of it, and you should get the idea of how much is left to raise.

I personally didn't see positives. In a couple of hints, what I got is:

- more shares to be sold in order to reach the 2.5 SE within the end of April through the ATM (if they are actually still trying to pursue that goal), considering that they only raised around 7.2 (if I do remember correctly) in the first quarter of 2018;
- triggering point of AGS-00 expected in the second half of the year (was it supposed to be in first half?), meaning that they most likely will need to raise more money anyway from today 'till year end, and thus (as it usually happens), most likely issue even more shares.

The first imminent triggering event I see right now is when the FDA will have a say on the protocol change at this point.

Obviously just my own opinion, please do your own DD.

The point is, IMHO, that if they raised 7.2M during the first quarter, they would need (always IMO) to raise substantial more money in order to be able to have 2.5 SE within the end of April, thus - if they chose as it seems to me - to do it through the issuance of common shares by using the ATM, they would need to sell still more shares.

Don't you think he showed overall some optimism in the presentation?

Do you guys have any clue of how much the pipeline would be worth, preclinical included?

You compare a 2017 speech with lots of data gathered meanwhile, with a much earlier slide (of PI/PII data). Congrats.

Already discussed tons of times.

China, you are in a message board where someone used to say that the stock could reach 70$ per share. A message board where most people fail to admit that there has been a strong dilution in the last years. Why bothering? Many of the people writing in this message board just don't have a clue about finance.

June? If the publication doesn't come out within next week, I personally see it ugly. Even at 0.5 with new share count market cap would be at around half of a billion, quite high in my opinion. Please make your own DD, but imo it's something to consider.

When was the pub first announced? June?